| Literature DB >> 23346418 |
Shafik N Wassef1, Pete S Batra, Samuel Barnett.
Abstract
Skull base inverted papilloma (IP) is an unusual entity for many neurosurgeons. IP is renowned for its high rate of recurrence, its ability to cause local destruction, and its association with malignancy. This paper is a comprehensive review of the reports, studies, and reviews published in the current biomedical literature from 1947 to September 2010 and synthesize this information to focus on its potential invasion to the base of the skull and possible intradural extension. The objective is to familiarize the clinician with the different aspects of this unusual disease. The role of modern diagnostic tools in medical imaging in order to assess clearly the limits of the tumors and to enhance the efficiency and the safety in the choice of a surgical approach is pointed out. The treatment guidelines for IP have undergone a complex evolution that continues today. Radical excision of the tumour is technically difficult and often incomplete. Successful management of IP requires resection of the affected mucosa which could be achieved with open surgery, endoscopic, or combined approach. Radio and chemotherapy were used for certain indications. More optimally research would be a multicenter randomized trials with large size cohorts.Entities:
Year: 2012 PMID: 23346418 PMCID: PMC3549337 DOI: 10.5402/2012/175903
Source DB: PubMed Journal: ISRN Surg ISSN: 2090-5785
Comparing IP to other Schneiderian papilloma.
| Papilloma | Fungiform | Inverted | Oncocytic Schneiderian |
|---|---|---|---|
| Former name/synonyms | Septal | Ringertz | Cylindrical, columnar |
|
| |||
| Prevalence % | 50 | 47 | 3–5 |
|
| |||
| Origin | Nasal septum | Lateral nasal wall and paranasal sinuses | Lateral nasal wall and paranasal sinuses |
|
| |||
| Epithelium | Everted, exophytic | Infolded, endophytic | |
|
| |||
| Microscopy | Thick squamous epithelium and, less frequently, respiratory epithelium arranged in papillary fronds | Thickened squamous epithelium admixed with mucocytes and intraepithelial mucous cysts | Multilayered epithelium with an eosinophilic cytoplasm among which intraepithelial mucin cysts |
|
| |||
| Age group | Younger | 50~60 | 30~80 |
|
| |||
| Malignancy | 35% have invasive squamous cell carcinoma | Locally aggressive, extending into the sinuses, the orbit, nasopharynx [ | 14%~19% |
|
| |||
| 25% multifocal | Mixed with typical inverted papilloma | ||
Presenting Symptoms.
| Nasal cavity lesions | Sinus lesions |
|---|---|
| Earlier | Later |
| Obstruction | Obstructive symptoms |
| Bleeding | Postnasal drip |
| Pansinusitis | Congestion pain |
List of common symptoms.
| List of symptoms |
|---|
| (i) Nasal obstruction, usually one sided |
| (ii) Rhinorrhea (runny nose) discharge |
| (iii) Epistaxis (nosebleed) |
| (iv) Sinusitis |
| (v) Facial pain |
| (vi) Loss of sense of smell |
| (vii) Frontal headache |
Signs and symptoms of invading IP, classified by site of invasion.
| Intracranial Invasion | Symptoms | Signs |
|---|---|---|
| Anterior cranial fossa via | Anosmia or symptoms related to | Anosmia, proptosis |
|
| ||
| Orbital involvement | Proptosis, periorbital swelling, | Impaired ocular mobility, anesthesia |
|
| ||
| Inferior extension into | Painful loose teeth, poorly fitting | Oral cavity mass on the palate, upper |
Krause staging system (2000) for inverted papilloma [324].
| Stage | Location and spread | Malignant changes |
|---|---|---|
| T1 | Tumor totally confined to the nasal cavity, without | There must be no |
|
| ||
| T2 | Tumor involving the ostiomeatal complex, and ethmoid | There must be no |
|
| ||
| T3 | Tumor involving the lateral, inferior, superior, anterior, | There must be no |
|
| ||
| T4 | All tumors with any extranasal/extrasinus extension to | All tumors associated |
Cannady's et al. staging system about prognosis (as operationally defined by RR) for IP managed by advanced endoscopic techniques.
| Group | Location and spread | Recurrence rate |
|---|---|---|
| Group A | IP confined to the nasal cavity, ethmoid sinus, | 3.0% |
| Group B | IP with lateral maxillary sinus, sphenoid sinus, | 19.8% |
| Group C | IP with extrasinus extension | 35.3% |
Indications of radiotherapy.
| Indications of radiotherapy in IP |
|---|
| Patients unwilling or unable to undergo surgery |
| Poor surgical candidates |
| Intolerable morbidity of the radical surgery |
| Advanced and biologically aggressive SPs |
| Associated malignancy |
| Incompletely resected IP |
| Unresectable lesions |
| Early recurrence |